Skip to main content

Table 2 Logistic model for predicting long PFS

From: Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study

Variables

OR (CI)

p-value

Total CTCs (< 3 vs 3 or more)

6.67E+14 (17.4 − ∞)

0.0004

DFS (60 months or more vs < 60)

2.32E+14 (2.78 − ∞)

0.020

  1. Italic values indicate significance of p value (p < 0.05)
  2. OR odds ratio, CI confidence interval